Afuco™ Anti-Human ADAM9 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-ADAM9 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. An anti-ADAM9 antibody enhances CD98-mediated cell aggregation, while it blocks CD98-mediated and RANKL-mediated multinucleated giant cell formation. A hydroxamate-based metalloprotease inhibitor, SI-27, which is found to suppress ADAM9 activity, suppresses multinucleated giant cell formation.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-016CL |
| Pricing | Inquiry |
| Host | Human |
| Target | ADAM9 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |